Stoke Therapeutics Inc (STOK) earnings · rev $184.4M
These earnings events as JSON? API free 100/dayStoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
This STOK earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported STOK revenue for 2025-12-31 was $184.4M. Net income was -$6.9M. Revenue was up 404.5% from 2024-12-31 to 2025-12-31. STOK currently screens at market cap $1.88B.
When the next STOK 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 404.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full STOK research stays on the stock page; the tape stays on the quote page.
STOK earnings FAQ
What are STOK's latest revenue and net income?
Latest cached Stoke Therapeutics Inc (STOK) revenue for Dec 31, 2025 was $184.4M. Net income was -$6.9M. Statements: https://lician.com/financials/stok
What is STOK's latest diluted EPS?
Latest cached Stoke Therapeutics Inc (STOK) diluted EPS for Dec 31, 2025 was -$0.12.
What period does the latest STOK earnings print cover?
The latest cached Stoke Therapeutics Inc (STOK) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did STOK revenue change from the prior cached period?
Cached Stoke Therapeutics Inc (STOK) revenue was up 404.5% from $36.6M (Dec 31, 2024) to $184.4M (Dec 31, 2025). Statements: https://lician.com/financials/stok
Where are STOK earnings listed?
Cached earnings facts for Stoke Therapeutics Inc (STOK) are listed at https://lician.com/earnings/stok. Statements: https://lician.com/financials/stok
Not investment advice.